Solifenacin succinate / tamsulosin hydrochloride


( Last Updated : March 2, 2015)
Generic Name:
Solifenacin succinate / tamsulosin hydrochloride
Project Status:
Withdrawn
Therapeutic Area:
Benign prostatic hyperplasia
Manufacturer:
Astellas Pharma Canada, Inc.
Call for patient/clinician input open:
Brand Name:
VesiFlow
Project Line:
Reimbursement Review
Project Number:
SR0424-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms